Consumer Insights
Uncover trends and behaviors shaping consumer choices today
Procurement Insights
Optimize your sourcing strategy with key market data
Industry Stats
Stay ahead with the latest trends and market analysis.
Explore Our Diverse Range Of Offerings
From detailed reports to experts services offered in 15+
Industry Domains
Add 2 More Reports For 20% off
Report Overview
According to clinical studies and epidemiological data, necrotizing enterocolitis (NEC) occurs in approximately 7% of extremely low birth weight infants in the United States, primarily affecting preterm infants, with mortality ranging from 20–30% and up to 50% post-surgical cases. As per necrotizing enterocolitis (NEC) epidemiology forecast by Expert Market Research, prevalence remains a critical neonatal concern.
2025
Base Year
2019-2025
Historical Period
2026-2035
Forecast Period
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Necrotizing Enterocolitis (NEC) Epidemiology Forecast Report Coverage
Expert Market Research's “Necrotizing Enterocolitis (NEC) Epidemiology Forecast Report 2026-2035” offers comprehensive information on the prevalence and demographics of necrotizing enterocolitis (NEC). It projects the future incidence and prevalence rates of necrotizing enterocolitis (NEC) cases across various populations. The study covers age, gender, and type as major determinants of the necrotizing enterocolitis (NEC) population. The report highlights patterns in the prevalence of necrotizing enterocolitis (NEC) over time and projects future trends based on multiple variables.
The report provides a comprehensive overview of the disease, as well as historical and projected data on the epidemiology of necrotizing enterocolitis (NEC) in the 8 major markets.
Regions Covered
- United States
- Germany
- France
- Italy
- Spain
- United Kingdom
- Japan
- India
Necrotizing Enterocolitis (NEC) Understanding: Disease Overview
Necrotizing enterocolitis (NEC) is a severe gastrointestinal condition primarily affecting premature and low birth weight infants. It occurs when inflammation and bacterial invasion damage the intestinal wall, potentially leading to tissue death and intestinal perforation. The exact cause is multifactorial, involving intestinal immaturity, abnormal gut microbiota, and feeding-related stress. NEC is generally classified into medical and surgical types based on severity and intestinal involvement. Clinical progression can be rapid and life-threatening if not identified early. Despite advances in neonatal care, NEC continues to present a considerable clinical and public health burden worldwide.
Key Report Insights
|
Parameter |
Insight |
|
Largest Patient Pool |
India |
|
Fastest Growing Region |
India |
|
High-Risk Population |
Preterm infants and extremely low birth weight (ELBW) neonates |
|
Key Diagnostic Method |
Abdominal radiography (pneumatosis intestinalis detection) |
|
Major Risk Factor |
Prematurity and immature gastrointestinal tract |
|
Major gap in the market |
Lack of early diagnostic biomarkers and targeted therapeutic options |
Necrotizing Enterocolitis (NEC) Epidemiology Perspective
The necrotizing enterocolitis (NEC) epidemiology division offers information on the patient pool from history to the present as well as the projected trend for each of the 8 major markets. Expert Market Research provides both current and predicted trends for the necrotizing enterocolitis (NEC) epidemiology scenario by examining a wide range of studies. Additionally, the report covers the diagnosed patient pool for necrotizing enterocolitis (NEC) and their trends. The data is broken down into specific categories, such as total prevalent cases in males and females, and total diagnosed cases across different age groups and patient pools.
|
Epidemiology Segment |
Key Insights |
|
Diagnosed Prevalent Cases of the Disease |
Necrotizing Enterocolitis (NEC) is a severe neonatal gastrointestinal emergency mainly affecting preterm and extremely low birth weight infants in NICUs. According to Bikila Balis et al., 2025, the pooled prevalence of NEC among NICU admissions is 16% (95% CI 11–22), while globally it ranges between 1% and 7%, reflecting variability across healthcare systems and neonatal care settings. |
|
Gender-Specific Cases of the Disease |
Available clinical evidence indicates that gender is not a consistent determinant of NEC occurrence. According to observational neonatal studies, both male and female infants are affected, and no statistically significant gender-based difference in incidence has been consistently established across reported populations. |
|
Age-Specific Cases of the Disease |
According to Tamas Toth et al., 2025, NEC primarily affects very low birth weight and extremely low birth weight infants, with prevalence ranging from 1% to 11% in VLBW infants and up to 22% in ELBW infants, highlighting strong association with prematurity and neonatal immaturity. |
|
Ethnicity-Wise Cases of the Disease |
According to Satoshi Kusuda et al., 2025, variation in NEC incidence has been observed across racial and ethnic groups, even within the same country, suggesting possible genetic and population-based differences contributing to epidemiological variability. |
|
Mortality and Survival Analysis of the Disease |
According to Tamas Toth et al., 2025, NEC is associated with significant mortality, with overall rates around 23.5%, and postoperative mortality reaching up to 50.9% in extremely low birth weight infants, indicating severe outcomes despite neonatal intensive care advancements. |
Type-Specific Disease Burden and Epidemiology Analysis
|
Disease Type |
Prevalence |
|
Medical NEC (Non-surgical NEC) |
Accounts for majority of total NEC cases in preterm infants. Most cases are managed with antibiotics, bowel rest, and supportive NICU care, with higher survival compared to surgical NEC, though incidence remains highest in extremely low birth weight neonates. |
|
Surgical NEC (Severe/Complicated NEC) |
Represents low but significant NEC cases. Requires surgical intervention due to bowel perforation or necrosis, and is associated with significantly higher mortality rates, often reaching up to 50% in extremely preterm infants. |
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Country-wise Necrotizing Enterocolitis (NEC) Epidemiology
The necrotizing enterocolitis (NEC) epidemiology data and findings for the United States, Germany, Spain, Italy, France, the United Kingdom, Japan, and India are also provided in the epidemiology section.
|
Country |
Key Insights |
|
United States |
According to provided epidemiological data, a survey in the United States revealed that approximately 7% of extremely low birth weight infants develop necrotizing enterocolitis, highlighting a significant burden among high-risk neonatal populations in intensive care units. |
|
Germany |
Recent European epidemiological evidence indicates that NEC incidence in preterm infants across regions including Germany generally ranges between 2% and 7%, depending on birth weight and gestational age distribution (Nathalie Lamireau et al., 2023). |
|
France |
In France, epidemiological findings reported by Nathalie Lamireau et al. (2023) show that approximately 60,000 children are born prematurely each year, and NEC affects between 2% and 7% of preterm infants, with EPIPAGE-2 reporting an incidence of 3.1% in infants born at 24–34 weeks of gestation. |
|
Italy |
Evidence from Nathalie Lamireau et al. (2023) suggests that NEC incidence in preterm infants in European populations, including Italy, generally ranges between 2% and 7%, particularly affecting very low birth weight neonates in neonatal intensive care units. |
|
Spain |
Published data by Nathalie Lamireau et al. (2023) indicate that NEC affects approximately 2% to 7% of preterm infants across European regions, including Spain, with a higher risk among extremely premature and low birth weight populations. |
|
United Kingdom |
Clinical evidence from the United Kingdom reported by Mary Eileen Foster et al. (2024) indicates that NEC incidence among NICU-admitted neonates ranges from 1% to 5%, with variation based on gestational age and birth weight categories. |
|
Japan |
According to Satoshi Kusuda et al., 2025, NEC incidence in Japan is approximately 1.6% among very low birth weight infants, which is lower compared to the United States and several European countries, indicating regional variation in disease burden. |
|
India |
As per Bikila Balis et al., 2025, the prevalence of NEC among NICU admissions in India is approximately 6.62%, reflecting a notable neonatal disease burden influenced by prematurity and healthcare variability. |
Key Market Gaps, Untapped Opportunities, and Emerging Growth Areas in the Regional Disease Epidemiology Landscape
Despite rising awareness of necrotizing enterocolitis (NEC), significant gaps persist in early diagnostic standardization and neonatal screening protocols across emerging healthcare systems. Limited access to advanced neonatal intensive care units and delayed recognition of early intestinal ischemia continue to worsen outcomes. There is a major unmet need for reliable biomarkers and non-invasive imaging tools for early detection. Additionally, region-specific epidemiological surveillance systems remain underdeveloped, creating opportunities for digital health integration, real-time neonatal monitoring platforms, and predictive analytics to improve survival rates and optimize NICU resource allocation.
Necrotizing Enterocolitis (NEC): Treatment Overview
The treatment of necrotizing enterocolitis (NEC) depends on disease severity and clinical presentation. Initial management includes bowel rest, nasogastric decompression, intravenous fluids, and broad-spectrum antibiotics to control infection and inflammation. In severe cases with perforation or necrosis, surgical intervention such as resection of damaged bowel or peritoneal drainage may be required. Supportive neonatal intensive care is critical throughout treatment to stabilize vital functions. Nutritional support is gradually reintroduced after recovery.
Key Questions Answered
- What is the current and projected burden of necrotizing enterocolitis (NEC) across the 8 major markets?
- Which countries across the 8 major markets account for the highest necrotizing enterocolitis (NEC) patient populations and fastest growth rates?
- What is the diagnosed versus undiagnosed patient population of necrotizing enterocolitis (NEC) across key countries in the 8 major markets?
- Which countries demonstrate the largest gaps in screening, early diagnosis, and disease awareness of necrotizing enterocolitis (NEC) across the 8 major markets?
- What are the major drivers contributing to the increasing burden of necrotizing enterocolitis (NEC) across the 8 major markets?
- How do major comorbidities and risk factors influence necrotizing enterocolitis (NEC) epidemiology trends across the 8 major markets?
- What are the regional trends in advanced disease progression, treatment uptake, and patient management of necrotizing enterocolitis (NEC) across the 8 major markets?
- Which patient segments represent the highest unmet clinical need in the necrotizing enterocolitis (NEC) landscape across the 8 major markets?
- Which therapeutic areas linked to necrotizing enterocolitis (NEC) are expected to witness the strongest growth opportunities across the 8 major markets?
- How is the necrotizing enterocolitis (NEC) epidemiology landscape expected to evolve over the next 5 to 10 years across the 8 major markets?
- Which countries across the 8 major markets offer the most attractive market opportunities based on necrotizing enterocolitis (NEC) epidemiology and healthcare infrastructure?
- Which epidemiological trends are expected to influence future drug development and market access strategies for necrotizing enterocolitis (NEC) across the 8 major markets?
Scope of the Necrotizing Enterocolitis (NEC) Epidemiology Report
- The report covers a detailed analysis of signs and symptoms, causes, risk factors, pathophysiology, diagnosis, treatment options, and classification/types of necrotizing enterocolitis (NEC) based on several factors.
- Necrotizing Enterocolitis (NEC) Epidemiology Forecast Report covers data for the eight major markets (the US, France, Germany, Italy, Spain, the UK, Japan, and India).
- The necrotizing enterocolitis (NEC) report helps to identify the patient population, and the unmet needs are highlighted along with an assessment of the disease's risk and burden.
Related Reports
Pricing Plans
Upto 15% Off
USD
-
$2699 $2429
-
$4299 $3869
-
$5799 $4949
-
$6999 $5949
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Report Summary
Explore our key highlights of the report and gain a concise overview of key findings, trends, and actionable insights that will empower your strategic decisions.
|
Report Features |
Details |
|
Base Year |
2025 |
|
Historical Period |
2019-2025 |
|
Forecast Period |
2026-2035 |
|
Epidemiology Statistics Provided |
|
|
Segmentation Provided |
|
|
Geographies Covered |
|
Datasheet
One User
USD 2,699
USD 2,429
tax inclusive*
- Selected Segments
- Printing Restrictions
- Excel Spreadsheet Delivered via Email
- Full Report
- Periodic Updates
- Post Sales Analysts Support
- Unlimited Prints
Single User License
One User
USD 4,299
USD 3,869
tax inclusive*
- All Segments
- Printing Restrictions
- PDF Delivered via Email
- Custom Report Layout
- Post Sales Analysts Support
- Periodic Updates
- Unlimited Prints
Five User License
Five User
USD 5,799
USD 4,949
tax inclusive*
- All Segments
- Five Prints Available
- PDF Delivered via Email
- Limited Free Customization
- Post Sales Analyst Support
- Custom Report Layout
- Periodic Updates
- Unlimited Prints
Corporate License
Unlimited Users
USD 6,999
USD 5,949
tax inclusive*
- All Segments
- Unlimited Prints Available
- PDF & Excel Delivery via Email
- Limited Free Customization
- Post Sales Analysts Support
- Discount On Next Update
- Custom Report Layout
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Bundle Type
Flash Bundle
20% OFF
Number of Reports: 3
Small Business Bundle
25% OFF
Number of Reports: 5
Growth Bundle
30% OFF
Number of Reports: 8
Enterprise Bundle
35% OFF
Number of Reports: 10
Overview
- Life Time Access
- Analyst Support Related to Report
- PDF Version of the Report
- Complimentary Excel Data Set
- Free Analyst Hours
- Complimentary Free 1 Month Subscription to Trade Data Base
- Complimentary One Month Subscription to Price Database (Chemicals only)
- Complimentary PPT Version of the Report
- Complimentary License Upgrade
- Complimentary Power BI Dashboards
- Life Time Access
- Analyst Support Related to Report
- PDF Version of the Report
- Complimentary Excel Data Set
- Free Analyst Hours - 50 Hours
- Complimentary Free 1 Month Subscription to Trade Data Base
- Complimentary One Month Subscription to Price Database (Chemicals only)
- Complimentary PPT Version of the Report
- Complimentary License Upgrade
- Complimentary Power BI Dashboards
- Life Time Access
- Analyst Support Related to Report
- PDF Version of the Report
- Complimentary Excel Data Set
- Free Analyst Hours - 80 Hours
- Complimentary Free 1 Month Subscription to Trade Data Base
- Complimentary One Month Subscription to Price Database (Chemicals only)
- Complimentary PPT Version of the Report
- Complimentary License Upgrade
- Complimentary Power BI Dashboards
- Life Time Access
- Analyst Support Related to Report
- PDF Version of the Report
- Complimentary Excel Data Set
- Free Analyst Hours - 100 Hours
- Complimentary Free 1 Month Subscription to Trade Data Base
- Complimentary One Month Subscription to Price Database (Chemicals only)
- Complimentary PPT Version of the Report
- Complimentary License Upgrade
- Complimentary Power BI Dashboards
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Number of Reports: 3
20%
tax inclusive*
- 3 Reports Included
- Life Time Acess
- Analyst Support Related to Report
- PDF Version of the Report
- Free 1 Month Subscription to Trade Data Base
- 1 Month Subscription to Price Database (Chemicals only)
- Complimentary Excel Data Set
- PPT Version of the Report
- Power BI Dashboards
- License Upgrade
- Free Analyst Hours
Small Business Bundle
Number of Reports: 5
25%
tax inclusive*
- 5 Reports Included
- Life Time Acess
- Analyst Support Related to Report
- PDF Version of the Report
- Complimentary Excel Data Set
- Free Analyst Hours - 50 Hours
- Free 1 Month Subscription to Trade Data Base
- 1 Month Subscription to Price Database (Chemicals only)
- Complimentary Excel Data Set
- PPT Version of the Report
- Power BI Dashboards
- License Upgrade
Growth Bundle
Number of Reports: 8
30%
tax inclusive*
- 8 Reports Included
- Life Time Acess
- Analyst Support Related to Report
- PDF Version of the Report
- Complimentary Excel Data Set
- Free Analyst Hours - 50 Hours
- Free 1 Month Subscription to Trade Data Base
- 1 Month Subscription to Price Database (Chemicals only)
- License Upgrade
- Free Analyst Hours - 80 Hours
- Power BI Dashboards
Enterprise Bundle
Number of Reports: 10
35%
tax inclusive*
- 10 Reports Included
- Life Time Acess
- Analyst Support Related to Report
- PDF Version of the Report
- Complimentary Excel Data Set
- Free Analyst Hours - 50 Hours
- Free 1 Month Subscription to Trade Data Base
- 1 Month Subscription to Price Database (Chemicals only)
- License Upgrade
- Power BI Dashboards
- Free Analyst Hours - 100 Hours
How To Order
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Strategic Solutions for Informed Decision-Making
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.
